Table 1 The clinical characteristics of eligible patients
Variables | Anticoagulation group (n = 46) | Control group (n = 38) | P value | |
|---|---|---|---|---|
Age (years) | 47.19 ± 15.79 | 49.61 ± 11.11 | 0.431 | |
Gender | Male | 32 | 26 | 0.91 |
Female | 14 | 12 | ||
Etiology | HBV | 34 | 28 | 0.995 |
HCV | 4 | 3 | ||
Alcohol | 3 | 3 | ||
Other | 5 | 4 | ||
Platelets (×109/l) | 89.89 ± 58.09 | 88.34 ± 54.17 | 0.901 | |
Serum total bilirubin (μmol/l) | 20.12 ± 11.51 | 18.34 ± 8.42 | 0.43 | |
Serum albumin (g/l) | 35.46 ± 5.49 | 36.73 ± 5.12 | 0.276 | |
Serum creatinine (μmol/l) | 70.57 ± 13.73 | 68.58 ± 16.12 | 0.55 | |
PT(s) | 14.68 ± 2.27 | 14.07 ± 1.83 | 0.192 | |
INR | 1.33 ± 0.21 | 1.31 ± 0.16 | 0.65 | |
CHILD score | 5.85 ± 0.92 | 5.71 ± 0.89 | 0.493 | |
CHILD grade | A | 36 | 31 | 0.706 |
B | 10 | 7 | ||
MELD score | 7.76 ± 3.28 | 7.28 ± 3.97 | 0.541 | |
Esophagogastric varices | Present | 26 | 21 | 0.908 |
Absent | 20 | 17 | ||
Previous variceal bleeding | Present | 18 | 16 | 0.782 |
Absent | 28 | 22 | ||
Ascite | Present | 10 | 7 | 0.706 |
Absent | 36 | 31 | ||
Splenectomy | Present | 16 | 13 | 0.956 |
Absent | 30 | 25 | ||
Vessel involvement | MPV only | 22 | 20 | 0.839 |
MPV+ SV only | 14 | 12 | ||
MPV+ SMV only | 8 | 4 | ||
MPV+ SV + SMV | 2 | 2 | ||
Follow up time | 51 | 44 | 0.099 | |